Limited Tissue Penetration of Taxanes: A Mechanism for Resistance in Solid Tumors

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Clinical Cancer Research

• Publication date

  2007-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/1078-0432.CCR-06-1941PMID 17473214
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The penetration of anticancer drugs through tumor tissue as a function of cellular adhesion and packing density of tumor cells.

  2006cited by this paper
• Drug penetration in solid tumours

  2006cited by this paper
• Cell kill kinetics and cell cycle effects of taxol on human and hamster ovarian cell lines

  2004cited by this paper
• Microregional Effects of Gemcitabine in HCT-116 Xenografts

  2004cited by this paper
• Direct Assessment of Drug Penetration into Tissue Using a Novel Application of Three-Dimensional Cell Culture

  2004cited by this paper
• Comparative in vitro cytotoxicity of taxol and Taxotere against cisplatin-sensitive and-resistant human ovarian carcinoma cell lines

  2004cited by this paper
• Tumor distribution of bromodeoxyuridine-labeled cells is strongly dose dependent.

  2003cited by this paper
• Pharmacological Effects of Formulation Vehicles

  2003cited by this paper
• Limited penetration of anticancer drugs through tumor tissue: a potential cause of resistance of solid tumors to chemotherapy.

  2002cited by this paper
• Influence of Cremophor El on the bioavailability of intraperitoneal paclitaxel.

  2002cited by this paper
• Biodistribution of paclitaxel and poly(l-glutamic acid)-paclitaxel conjugate in mice with ovarian OCa-1 tumor

  2000cited by this paper
• The influence of expression of P‐glycoprotein on the penetration of anticancer drugs through multicellular layers

  2000cited by this paper
• Cremophor reduces paclitaxel penetration into bladder wall during intravesical treatment

  1999cited by this paper
• Determinants of Paclitaxel Penetration and Accumulation in Human Solid Tumor 1

  1999cited by this paper
• Determinants of paclitaxel penetration and accumulation in human solid tumor.

  1999cited by this paper
• Measurement of delivery and metabolism of tirapazamine to tumour tissue using the multilayered cell culture model

  1999cited by this paper
• Preclinical pharmacokinetics of paclitaxel and docetaxel.

  1998cited by this paper
• Evaluation of a novel in vitro assay for assessing drug penetration into avascular regions of tumours.

  1998cited by this paper
• An experimental and mathematical model for the extravascular transport of a DNA intercalator in tumours.

  1997cited by this paper
• Delivery of Molecular and Cellular Medicine to Solid Tumors

  1997cited by this paper
• Influence of drug exposure parameters on the activity of paclitaxel in multicellular spheroids.

  1997cited by this paper
• Bladder tissue pharmacokinetics of intravesical taxol

  1997cited by this paper
• Multilayers of cells growing on a permeable support. An in vitro tumour model.

  1997cited by this paper
• Binding of taxol to plastic and glass containers and protein under in vitro conditions.

  1996cited by this paper
• Multicellular membranes as an in vitro model for extravascular diffusion in tumours.

  1996cited by this paper
• Nonlinear pharmacokinetics of paclitaxel in mice results from the pharmaceutical vehicle Cremophor EL.

  1996cited by this paper
• Preclinical evaluation of docetaxel (Taxotere).

  1995cited by this paper
• Preclinical pharmacology of docetaxel.

  1995cited by this paper
• Drug and radiation resistance in spheroids: cell contact and kinetics

  1994cited by this paper
• Comparative effects of taxol and Taxotere on two different human carcinoma cell lines

  1994cited by this paper
• Comparison of paclitaxel and docetaxel activity on human ovarian carcinoma xenografts.

  1994cited by this paper
• Transport of molecules in the tumor interstitium: a review.

  1987cited by this paper

• Bridging the resolution gap in alpha therapy dosimetry: a space for quantitative MRI?

  2025cites this paper
• Nebulized Bacterioruberin/Astaxanthin-Loaded Nanovesicles: Antitumoral Activity and Beyond

  2025cites this paper
• Influence of Bathophenanthroline in Cu-Naringenin complexes on 3D culture anticancer activity, antimetastatic properties and synergy with the antidepressant paroxetine.

  2025cites this paper
• A perfusion-based model to explain how paclitaxel achieves tumour-selective killing

  2025cites this paper
• Phase I/II Study of AXL-Specific Antibody–Drug Conjugate Enapotamab Vedotin in Patients with Advanced Solid Tumors

  2025influential citation
• Nebulized inhalation drug delivery: clinical applications and advancements in research.

  2024cites this paper
• Accumulation of liposomes in metastatic tumor sites is not necessary for anti-cancer drug efficacy

  2024cites this paper
• Radiation and chemo-sensitizing effects of DNA-PK inhibitors are proportional in tumors and normal tissues.

  2024cites this paper
• Ultrasound-triggered drug release and cytotoxicity of microbubbles with diverse drug attributes

  2024cites this paper
• Pulmonary inhalation for disease treatment: Basic research and clinical translations

  2024cites this paper
• Drug delivery process simulation—Quantifying the conformation dynamics of paclitaxel and cremophor EL

  2024cites this paper
• Anatomical Targeting of Anticancer Drugs to Solid Tumors Using Specific Administration Routes: Review

  2023cites this paper
• Effect of paclitaxel priming on doxorubicin penetration in a multicellular layer model of human colorectal cancer cells.

  2023cites this paper
• SOX combined with intraperitoneal perfusion of docetaxel compared with DOS regimen in the first-line therapy for advanced gastric cancer with malignant ascites: a prospective observation

  2022cites this paper
• A CFH peptide-decorated liposomal oxymatrine inactivates cancer-associated fibroblasts of hepatocellular carcinoma through epithelial–mesenchymal transition reversion

  2022cites this paper
• Tissue-reactive drugs enable materials-free local depots.

  2022cites this paper
• Strategies to improve drug penetration into tumor microenvironment by nanoparticles: focus on nanozymes

  2022cites this paper
• Sustained Supratherapeutic Paclitaxel Delivery Enhances Irreversible Sarcoma Cell Death.

  2022cites this paper
• A thermo-sensitive hydrogel composed of methylcellulose/hyaluronic acid/silk fibrin as a biomimetic extracellular matrix to simulate breast cancer malignancy

  2022cites this paper
• Role of extracellular vesicles secretion in paclitaxel resistance of prostate cancer cells

  2022cites this paper
• Current Nano-Strategies to Improve Therapeutic Efficacy Across Special Structures

  2022cites this paper
• Chemotherapeutic effects on breast tumor hemodynamics revealed by eigenspectra multispectral optoacoustic tomography (eMSOT)

  2021cites this paper
• Alginate-based 3D cell culture technique to evaluate the half-maximal inhibitory concentration: an in vitro model of anticancer drug study for anaplastic thyroid carcinoma

  2021cites this paper
• Fibrinolytic nanocages dissolve clots in the tumor microenvironment, improving the distribution and therapeutic efficacy of anticancer drugs

  2021cites this paper
• Antibody drug conjugates in gastrointestinal cancer: From lab to clinical development.

  2021cites this paper
• Extracellular Matrices and Cancer-Associated Fibroblasts: Targets for Cancer Diagnosis and Therapy?

  2021cites this paper
• A Two-Photon Microimaging-Microdevice System for Four-Dimensional Imaging of Local Drug Delivery in Tissues

  2021cites this paper
• Cytotoxic and chemosensitizing effects of glycoalkaloidic extract on 2D and 3D models using RT4 and patient derived xenografts bladder cancer cells.

  2021cites this paper
• Inter-Metastatic Heterogeneity of Tumor Marker Expression and Microenvironment Architecture in a Preclinical Cancer Model

  2021cites this paper
• Glioma stem cells and their roles within the hypoxic tumor microenvironment

  2021cites this paper
• Drug-eluting embolic microspheres: State-of-the-art and emerging clinical applications

  2021cites this paper
• Therapeutic peptides for chemotherapy: trends and challenges for advanced delivery systems.

  2021cites this paper
• Benzimidazole-Based Organic-Inorganic Gold Nanohybrids Suppress Invasiveness of Cancer Cells by Modulating EMT Signaling Cascade.

  2020cites this paper
• An Automatable Hydrogel Culture Platform for Evaluating Efficacy of Antibody-based Therapeutics in Overcoming Chemoresistance.

  2020cites this paper
• Maximizing the Value of Cancer Drug Screening in Multicellular Tumor Spheroid Cultures: A Case Study in Five Head and Neck Squamous Cell Carcinoma Cell Lines

  2020cites this paper
• Effects of microtubule-inhibiting small molecule and antibody-drug conjugate treatment on differentially-sized A431 squamous carcinoma spheroids

  2020cites this paper
• Effects of molecular weight and structural conformation of multivalent-based elastin-like polypeptides on tumor accumulation and tissue biodistribution

  2020cites this paper
• Cellular rewiring in lethal prostate cancer: the architect of drug resistance

  2020cites this paper
• Exploring the tumour microenvironment with non-invasive Magnetic Resonance Imaging techniques

  2020cites this paper
• Breast cancer nanomedicine market update and other industrial perspectives of nanomedicine

  2020cites this paper
• Targeted uptake of folic acid-functionalized polymeric nanoparticles loading glycoalkaloidic extract in vitro and in vivo assays.

  2020cites this paper
• Intra-tumoral drug concentration mapping within solid tumor micro-milieu using in-vitro model and doxorubicin as a model drug

  2020cites this paper
• Emerging Technologies for Local Cancer Treatment

  2020cites this paper
• Pharmacotherapeutic Botanicals for Cancer Chemoprevention

  2020influential citation
• Anti-VCAM-1 and Anti-IL4Rα Aptamer-Conjugated Super Paramagnetic Iron Oxide Nanoparticles for Enhanced Breast Cancer Diagnosis and Therapy

  2020cites this paper
• Nanomedicines for Breast Cancer Theranostics

  2020cites this paper
• Modeling of Nanotherapy Response as a Function of the Tumor Microenvironment: Focus on Liver Metastasis

  2020cites this paper
• Natural Products as Chemosensitizers for Adjunct Therapy in Cancer Management

  2020cites this paper
• Application of an open-chamber multi-channel microfluidic device to test chemotherapy drugs

  2020cites this paper
• Tyrosine kinase inhibitors and their unique therapeutic potentialities to combat cancer.

  2020cites this paper
• Drug Exposure to Establish Pharmacokinetic–Response Relationships in Oncology

  2019cites this paper
• Assessing the cytotoxic potential of glycoalkaloidic extract in nanoparticles against bladder cancer cells

  2019cites this paper
• Inhalation of sustained release microparticles for the targeted treatment of respiratory diseases

  2019cites this paper
• Targeting multidrug resistance in cancer by natural chemosensitizers

  2019cites this paper
• Breaking the ctDNA sensitivity barrier

  2019cites this paper
• A one-stop microfluidic-based lung cancer organoid culture platform for testing drug sensitivity.

  2019cites this paper
• The challenge of drug resistance in cancer treatment: a current overview

  2018cites this paper
• Functionalized Nanoparticles Efficiently Enhancing the Targeted Delivery, Tumor Penetration, and Anticancer Activity of 7‐Ethyl‐10‐Hydroxycamptothecin

  2018cites this paper
• Chloroquine in combination with aptamer-modified nanocomplexes for tumor vessel normalization and efficient erlotinib/Survivin shRNA co-delivery to overcome drug resistance in EGFR-mutated non-small cell lung cancer.

  2018cites this paper
• Heterogeneous distribution of trastuzumab in HER2-positive xenografts and metastases: role of the tumor microenvironment

  2018cites this paper
• Bystander Effects of Hypoxia-Activated Prodrugs: Agent-Based Modeling Using Three Dimensional Cell Cultures

  2018cites this paper
• Tumor Microenvironment Targeted Nanotherapy

  2018cites this paper
• Chemoresistance of Cancer Cells: Requirements of Tumor Microenvironment-mimicking In Vitro Models in Anti-Cancer Drug Development

  2018cites this paper
• Analyse multi-niveaux en biologie systémique computationnelle : le cas des cellules HeLa sous traitement apoptotique. (Multi-level analysis in computational system biology : the case of HeLa cells under apoptosis treatment)

  2018cites this paper
• Tumour tissue transport after intraperitoneal anticancer drug delivery

  2017cites this paper
• High-Content Screening Comparison of Cancer Drug Accumulation and Distribution in Two-Dimensional and Three-Dimensional Culture Models of Head and Neck Cancer

  2017cites this paper
• A non-equilibrium thermodynamic model for tumor extracellular matrix with enzymatic degradation

  2017cites this paper
• Conversion Surgery Post-Intraperitoneal Paclitaxel and Systemic Chemotherapy for Gastric Cancer Carcinomatosis Peritonei. Are We Ready?

  2017cites this paper
• Early use of chemotherapy in metastatic prostate cancer.

  2017cites this paper
• MALDI Mass Spectrometry Imaging for Evaluation of Therapeutics in Colorectal Tumor Organoids

  2017cites this paper
• Influence of a Basic Side Chain on the Properties of Hypoxia-Selective Nitro Analogues of the Duocarmycins: Demonstration of Substantial Anticancer Activity in Combination with Irradiation or Chemotherapy.

  2017cites this paper
• Importance of Drug Pharmacokinetics at the Site of Action

  2017cites this paper
• Nanomedicines and Combination Therapy of Doxorubicin and Olaparib for Treatment of Ovarian Cancer

  2016influential citation
• Mathematical Based Calculation of Drug Penetration Depth in Solid Tumors

  2016cites this paper
• Capturing tumor complexity in vitro: Comparative analysis of 2D and 3D tumor models for drug discovery

  2016cites this paper
• In vitro cancer cell-ECM interactions inform in vivo cancer treatment.

  2016cites this paper
• Diagnosis of cancer multidrug resistance by bacterium-mediated imaging.

  2016cites this paper
• Imaging Techniques for Evaluation of Drug Distribution in Solid Tumor

  2016cites this paper
• Docetaxel in Advanced and Castration Resistant Prostate Cancer

  2016cites this paper
• Multi-modal magnetic resonance imaging and histology of vascular function in xenografts using macromolecular contrast agent hyperbranched polyglycerol (HPG-GdF).

  2016cites this paper
• Nuevas estrategias terapéuticas para el cáncer de próstata

  2015cites this paper
• Nanotechnology in the war against cancer: new arms against an old enemy - a clinical view.

  2015cites this paper
• Tumor Effect‐Site Pharmacokinetics: Mechanisms and Impact on Efficacy

  2015cites this paper
• Modulation of intraperitoneal (IP) chemotherapy in ovarian cancer

  2015cites this paper
• Development of a tumor tissue-mimicking model with endothelial cell layer and collagen gel for evaluating drug penetration.

  2015cites this paper
• Breakthrough therapy for peritoneal carcinomatosis of gastric cancer: Intraperitoneal chemotherapy with taxanes.

  2015cites this paper
• Improving drug delivery to solid tumors: priming the tumor microenvironment.

  2015cites this paper
• Therapeutic properties of a vector carrying the HSV thymidine kinase and GM-CSF genes and delivered as a complex with a cationic copolymer

  2015cites this paper
• Chemotherapy in Prostate Cancer

  2015cites this paper
• Silicate fiber scaffold-based 3D perfusion cultures of the human colorectal cancer cell line HT-29 by using a microfluidic chip

  2015cites this paper
• Development and Intratumoral Distribution of Block Copolymer Micelles as Nanomedicines for the Targeted Delivery of Chemotherapy to Solid Tumors

  2014cites this paper
• Intratumor Heterogeneity and Its Impact on Drug Distribution and Sensitivity

  2014cites this paper
• Cancer Therapy : Preclinical Use of the Proton Pump Inhibitor Pantoprazole to Modify the Distribution and Activity of Doxorubicin : A Potential Strategy to Improve the Therapy of Solid Tumors

  2014cites this paper
• Chemotherapy and its evolving role in the management of advanced prostate cancer

  2014cites this paper
• Models and Technologies Effect of Small-Molecule Modi fi cation on Single-Cell Pharmacokinetics of PARP Inhibitors

  2014cites this paper
• Treatment strategies for gastric cancer patients with peritoneal metastasis

  2014cites this paper
• A Model Based Analysis of IPEC Dosing of Paclitaxel in Rats

  2014cites this paper
• Effect of Small-Molecule Modification on Single-Cell Pharmacokinetics of PARP Inhibitors

  2014cites this paper
• Salvage Gastrectomy After Intravenous and Intraperitoneal Paclitaxel (PTX) Administration with Oral S-1 for Peritoneal Dissemination of Advanced Gastric Cancer with Malignant Ascites

  2014cites this paper
• The path of anti-tuberculosis drugs: from blood to lesions to mycobacterial cells

  2014cites this paper